AVBP — ArriVent BioPharma, Inc. stock price, charts and financials

QT70ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.49
+1.85+6.24%
OverviewShort InterestFilings
AVBPQT70ArriVent BioPharma, Inc.·NASDAQ
31.49+6.24%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 22, 20268-KCurrent report
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
May 11, 202610-QQuarterly report
May 11, 2026424B5Prospectus
May 11, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEF 14ADefinitive proxy statement
Mar 17, 20268-KCurrent report
Mar 05, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 05, 20268-KCurrent report
Mar 05, 202610-KAnnual report
Mar 05, 2026S-8Registration of employee benefit securities
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 04, 20264Statement of changes in beneficial ownership
Feb 04, 20264Statement of changes in beneficial ownership
Feb 04, 20264Statement of changes in beneficial ownership
Feb 04, 20264Statement of changes in beneficial ownership
#1 / 25 of 150
Page
▼
/ 6